Objectives:

1. Recognize the importance of RVEF in prognosticating patients with pulmonary arterial hypertension.

2. Recognize that RVEDV/LVEDV ratio is a more sensitive marker than RVEDVi for RV dilation, and its severity can be defined by mortality.

3. Recognize that CMR allows for detailed size, volume, mass, blood flow, and tissue characterization of the RV which enables us to understand the RV better in order to target treatment in PAH.

 

Session date: 
Friday, October 27, 2017 - 12:00pm to 1:00pm
Speaker Name: 
Yuchi Han, MD, MMSc, FACC, FASE
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.